First Breakthrough in Liver Cancer Treatment in 20 Years
A Breakthrough in Liver Cancer Treatment: Combining Pembrolizumab and Lenvatinib Shows Promise For two decades,chemoembolization has been the standard treatment for hepatocellular carcinoma (HCC),a especially aggressive form of liver cancer.While this method, pioneered by Hospital Clínic de Barcelona and Idibaps, has offered patients an average survival of 20-30 months, the search for more effective treatments […]